Insider trades
Kooij Louise Frederika, CAO of NewAmsterdam Pharma NAMS, has filed 0 purchases and 19 sales on the open market. Over the past 12 months that comes to a net sale of $13.6M. The latest trade was on 06/22.
Kooij Louise Frederika
Chief Accounting Officer
- Company
- NewAmsterdam Pharma NAMS
- First filing
- 24/01/03
- Trades
- 59 trades
- Buys / sales
- 0 / 19
- 12-month net buying
- −$13.6M
- Last trade
- 06/22
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
NAMS | Open-market sale10b5-1 plan | 06/22 | 06/24 | 40,000 sh2 trades | $30.20avg. | $1,208,159 | −62.2% |
| Open-market sale10b5-1 plan | 05/26 | 05/27 | 65,000 sh | $35.69 | $2,319,850 | −72.7% | |
NAMS | Open-market sale10b5-1 plan | 01/27–01/28 | 01/29 | 72,428 sh2 trades | $32.25avg. | $2,335,859.52 | −74.8% |
NAMS | Open-market sale10b5-1 plan | 01/23–01/26 | 01/27 | 72,572 sh4 trades | $33.29avg. | $2,415,843.11 | −74.9% |
| Open-market sale10b5-1 plan | 01/05 | 01/07 | 2,647 sh | $33.25 | $88,012.75 | −17.6% | |
NAMS | Open-market sale10b5-1 plan | 25/12/23–25/12/26 | 25/12/29 | 145,000 sh3 trades | $35.84avg. | $5,196,740.65 | −90.6% |
NAMS | Open-market sale | 25/09/09 | 25/09/10 | 150,000 sh2 trades | $25.83avg. | $3,874,016.8 | −90.9% |
| Open-market sale | 25/09/03 | 25/09/05 | 18,073 sh | $25.09 | $453,451.57 | −54.6% | |
| Open-market sale | 25/08/25 | 25/08/27 | 8,269 sh | $24.86 | $205,567.34 | −35.5% | |
| Open-market sale | 25/03/04 | 25/03/05 | 150,000 sh | $20.37 | $3,055,500 | −90.9% | |
| Open-market sale | 24/10/01 | 24/10/01 | 45,000 sh | $15.72 | $707,400 | −100.0% |